Alembic Pharmaceuticals Limited Cash Flow Conversion Efficiency
Alembic Pharmaceuticals Limited cash flow conversion efficiency. Based on the latest financial reports, Alembic Pharmaceuticals Limited (APLLTD) has a cash flow conversion efficiency ratio of 0.076x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs4.03 Billion ≈ $43.57 Million USD) by net assets (Rs53.16 Billion ≈ $574.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Alembic Pharmaceuticals Limited (2011–2025)
Cash flow conversion efficiency of Alembic Pharmaceuticals Limited from 2011 to 2025. This chart illustrates how Alembic Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Alembic Pharmaceuticals Limited share price for real-time trading data and today's change.
Alembic Pharmaceuticals Limited Cash Flow Conversion Ratio Explained
Alembic Pharmaceuticals Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Alembic Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alembic Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Also see APLLTD company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Migros Ticaret AS
IS:MGROS
|
0.172x |
|
Greentown China Holdings Limited
F:G7C
|
0.081x |
|
Austevoll Seafood ASA
OL:AUSS
|
0.066x |
|
Chow Tai Seng Jewellery Co Ltd
SHE:002867
|
0.026x |
|
Flight Centre Travel Group Ltd
AU:FLT
|
-0.051x |
|
China National Gold Group Gold Jewellery Co Ltd
SHG:600916
|
0.003x |
|
Aksa Enerji Uretim AS
IS:AKSEN
|
0.018x |
|
Ora Banda Mining Ltd
AU:OBM
|
0.452x |
Annual Cash Flow Conversion Efficiency for Alembic Pharmaceuticals Limited (2011–2025)
The table below shows the annual cash flow conversion efficiency of Alembic Pharmaceuticals Limited from 2011 to 2025. Review how much free cash does Alembic Pharmaceuticals Limited generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs51.90 Billion ≈ $561.23 Million |
Rs879.70 Million ≈ $9.51 Million |
0.017x | -89.83% |
| 2024-03-31 | Rs48.18 Billion ≈ $521.07 Million |
Rs8.03 Billion ≈ $86.86 Million |
0.167x | +0.64% |
| 2023-03-31 | Rs43.70 Billion ≈ $472.65 Million |
Rs7.24 Billion ≈ $78.29 Million |
0.166x | +57.07% |
| 2022-03-31 | Rs52.38 Billion ≈ $566.42 Million |
Rs5.52 Billion ≈ $59.73 Million |
0.105x | -63.48% |
| 2021-03-31 | Rs50.67 Billion ≈ $547.97 Million |
Rs14.63 Billion ≈ $158.26 Million |
0.289x | +105.16% |
| 2020-03-31 | Rs31.90 Billion ≈ $345.04 Million |
Rs4.49 Billion ≈ $48.57 Million |
0.141x | -52.88% |
| 2019-03-31 | Rs27.18 Billion ≈ $293.94 Million |
Rs8.12 Billion ≈ $87.81 Million |
0.299x | +112.32% |
| 2018-03-31 | Rs22.20 Billion ≈ $240.13 Million |
Rs3.12 Billion ≈ $33.79 Million |
0.141x | -7.37% |
| 2017-03-31 | Rs19.01 Billion ≈ $205.61 Million |
Rs2.89 Billion ≈ $31.23 Million |
0.152x | -73.87% |
| 2016-03-31 | Rs16.01 Billion ≈ $173.09 Million |
Rs9.30 Billion ≈ $100.62 Million |
0.581x | +199.39% |
| 2015-03-31 | Rs8.85 Billion ≈ $95.67 Million |
Rs1.72 Billion ≈ $18.58 Million |
0.194x | -44.47% |
| 2014-03-31 | Rs6.76 Billion ≈ $73.06 Million |
Rs2.36 Billion ≈ $25.55 Million |
0.350x | -33.59% |
| 2013-03-31 | Rs5.03 Billion ≈ $54.39 Million |
Rs2.65 Billion ≈ $28.64 Million |
0.527x | +47.78% |
| 2012-03-31 | Rs3.95 Billion ≈ $42.72 Million |
Rs1.41 Billion ≈ $15.22 Million |
0.356x | +9.39% |
| 2011-03-31 | Rs2.95 Billion ≈ $31.93 Million |
Rs961.81 Million ≈ $10.40 Million |
0.326x | -- |
About Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal healt… Read more